Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam

Background: The World health organization (WHO) recently recommended standardized all-oral shorter regimens for rifampicin resistant Tuberculosis (RR-TB). For highly resistant Tuberculosis patients such as pre-XDR-TB: RR-TB plus additional resistance to fluoroquinolones (FQ), the 6–9-months bedaquil...

Descripció completa

Dades bibliogràfiques

Autors principals:	Thi Mai Phuong Nguyen, Binh Hoa Nguyen, Thi Thanh Thuy Hoang, Hoang Anh Nguyen, Dinh Hoa Vu, Mai Hoa Nguyen, Bao Ngoc Nguyen, Tom Decroo, Viet Nhung Nguyen
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-10-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	pre-XDR TB treatment all oral regimen injectable secondline drug QT prolongation bedaquline
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1023704/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!